DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.61 (2015) >

Please use this identifier to cite or link to this item: http://ir.fmu.ac.jp/dspace/handle/123456789/466

Files in This Item:

File Description SizeFormat
FksmJMedSci_61_p79.pdf578.85 kBAdobe PDFDownload
Title: Stenting strategy and follow-up results of multi-center registry in Fukushima city for left main coronary artery disease: bare metal stent versus drug-eluting stent
Authors: Nakazato, Kazuhiko
Mizukami, Hiroyuki
Ohtake, Hideki
Sakamoto, Nobuo
Yamaki, Takayoshi
Yamaguchi, Osamu
Kunii, Hiroyuki
Ohwada, Takayuki
Takeishi, Yasuchika
Affiliation: 循環器・血液内科学講座
Source title: Fukushima Journal of Medical Science
Volume: 61
Issue: 1
Start page: 79
End page: 85
Issue Date: 2015
Abstract: An appropriate treatment strategy for left main trunk (LMT) lesions is still controversial in the drug-eluting stent (DES) era. Consecutive LMT stenting cases (n = 155) between January 2008 and January 2013 in 4 hospitals in Fukushima city were retrospectively analyzed. We excluded the patients suffering from cardiogenic shock before the stenting procedure. Among those cases, 60 patients had acute coronary syndrome, and remaining 95 had stable angina pectoris. Out of 155 cases, 45 patients were treated with bare metal stents (BMSs) and 110 patients were treated with DESs. All cases were succeeded in the initial procedure. Mean stent size of BMS was 3.85 ± 0.34 mm while that of DES was 3.46 ± 0.17 mm (P<0.001). At the follow up coronary angiography (255-day on average), % stenosis of BMS group was 26.6 ± 15.0% and that of DES group was 20.4 ± 12.6% (P = 0.006). The mean observation period for clinical events was 738.8 ± 480.3 days. Major adverse cardiac events-free rates for each group were compared and no significant differences were evident between the 2 groups (11.1% vs. 19.1%, ns). The present study demonstrated that use of BMSs would be a viable option in the treatment of LMT lesions when it is possible to use a large-sized stent (>3.5 mm).
Publisher: The Fukushima Society of Medical Science
Publisher (Alternative foam): 福島医学会
language: eng
URI: http://ir.fmu.ac.jp/dspace/handle/123456789/466
Full text URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/466/1/FksmJMedSci_61_p79.pdf
ISSN: 0016-2590
DOI: 10.5387/fms.2015-5
PubMed ID: 26135665
Related Page: http://doi.org/10.5387/fms.2015-5
Rights: © 2015 The Fukushima Society of Medical Science
Appears in Collections:Vol.61 (2015)

Files in This Item:

File Description SizeFormat
FksmJMedSci_61_p79.pdf578.85 kBAdobe PDFDownload

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard